April 16, 2019
A national study has found that PET scans significantly influenced clinical management of patients with dementia.
August 2, 2018
The ADDF looks back at the 2018 Alzheimer's Association International Conference.
December 28, 2017
Learn what a biomarker is, why they matter to the ADDF, which biomarkers we have, and which ones we need.
March 6, 2017
Dr. Howard Fillit explains the importance of prevention to the ADDF's mission and our current efforts, including clinical trials.
November 25, 2016
Eli Lilly announced that its Alzheimer's drug solanezumab failed in its last phase 3 clinical trial. Howard Fillit, MD, discusses what this means, and where we go from here.
September 2, 2016
A treatment has reduced beta-amyloid plaques in the brains of patients with Alzheimer’s disease.
February 25, 2016
Grantee Dr. Frank Longo's promising new drug to treat Alzheimer's is on the cover of Time magazine.
June 10, 2015
Investing more in drug discovery and development is the best chance we have for finding a cure for Alzheimer's disease.
August 19, 2013
I recently saw a patient who was afraid he had Alzheimer's disease. A new scan made it easy to give him an accurate diagnosis. So why can't most patients use it?
June 4, 2013
The current costs of dementia care are enormous. But the future costs could create a crippling financial burden on our society, as the number of people diagnosed with dementia is expected to more than double in the next 30 years.